Slide 1 Raising the bar of efficacy in cancer therapeutics Alberto Sobrero Ospedale San Martino Genova, Italy Slide 2 Today’s topic: size of benefit in phase III clinical…

Slide 1 Which difference should we target? Alberto Sobrero Ospedale San Martino IRCCS Genova, Italy Slide 2 Which delta should we target? Delta for deciding GO - NO GO to…

Slide 1HIGH DOSE RADIOTHERAPY IN THE TREATMENT OF PLEURAL MESOTHELIOMA AFTER PLEURECTOMY/DECORTICATION OR BIOPSY: LONG TERM FOLLW UP, ACUTE AND LATE TOXICITY Parisi E, Romeo…

Slide 1Clinical Case Nº2 Dr. Javier Martín-Broto Slide 2 Case description 49-year-old man 1 st symptom/sign: Mild pain in right buttock 1 st diagnosis: Core-biopsy: Monophasic…

Slide 1 1 Cancer Immunotherapy: Fundamental Concepts and Emerging Role Oncology Perspective Slide 2 2 Learning Objectives Review the evidence supporting the immune system’s…

Slide 1 Diffuse large B-cell lymphoma Updates on therapy and monitoring Mark Roschewski, M.D. Lymphoid Malignancy Branch, Center for Cancer Research National Cancer Institute,…

Slide 1 Novel Biologic Therapies for Second-Line Gastric Cancer Charles S. Fuchs, MD Dana-Farber Cancer Institute Harvard Medical School Boston, MA Slide 2 Second-Line Therapy…

Slide 1 Slide 2 Laparoscopic Surgical Management of Epithelial Ovarian Cancer Cagatay Taskiran, MD, Assoc. Prof. VKV American Hospital, Division of Gynecologic Oncology Slide…

Slide 1 Cesare Gridelli Cesare Gridelli Division of Medical Oncology Division of Medical Oncology “S.G. Moscati” Hospital – Avellino (Italy) “S.G. Moscati” Hospital…

Slide 1 Challenging Cases in Cancer: Integration of Findings from ASCO 2007 Gastrointestinal Stromal Tumors Charles D. Blanke, MD, FACP Associate Professor of Medicine Director…